# Impact of Anti-HLA Donor-specific Antibodies in ABO-incompatible Kidney Transplantation

> **NCT03423901** · NA · COMPLETED · sponsor: **University Hospital, Toulouse** · enrollment: 58 (actual)

## Conditions studied

- Kidney Transplant

## Interventions

- **OTHER:** Blood sampling

## Key facts

- **NCT ID:** NCT03423901
- **Lead sponsor:** University Hospital, Toulouse
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-06
- **Primary completion:** 2018-05-02
- **Final completion:** 2018-05-05
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2019-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03423901

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03423901, "Impact of Anti-HLA Donor-specific Antibodies in ABO-incompatible Kidney Transplantation". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03423901. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*